How you can make 1,000% by investing

4 investing lessons from my first ten-bagger

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

"Ten bagger" was a term investing legend and fund manager Peter Lynch coined in his book One Up on Wall Street. It refers to an investment that appreciates to 10 times its initial purchase price – the equivalent of a 1,100% return.

If you haven't read the book I can thoroughly recommend it.

Lynch was manager of the Fidelity Magellan Fund from 1977 to 1990. Over that period of time, the fund grew from US$18 million to $19 billion by the time he left, and produced an annual return of more than 29% on average.

Recently, one of the stocks I own became my first ten bagger – not a bad return in just two years.Back in November 2012, I purchased shares in a small diagnostic imaging company focused on Melbourne, Victoria. Capitol Health Ltd (ASX: CAJ) shares were trading at around 8.8 cents at the time. They are currently trading at 85 cents. Including dividends and shares received in dividend reinvestment plans (DRPs), my total return is more than 1,000%. By comparison, over the same period, the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has climbed just over 30%, including dividends reinvested.

So what are some of the lessons we can take from this?

  1. Smaller companies have more potential to multi-bag than large cap stocks such as Woolworths Limited (ASX: WOW), Telstra Corporation Ltd (ASX: TLS) or CSL Limited (ASX: CSL).
  2. Getting in early can be important – but not essential. As an example, Ramsay Health Care Limited (ASX: RHC) shares were trading as low as 74 cents in 1999. Buying shares after they had risen to $5.70 in 2004 would still have seen investors score a ten bagger, with shares currently trading at $57.54.
  3. Ignore the market's ups and downs. It also means becoming somewhat of an outcast, holding on when everyone else is selling, and conquering your investing fears.
  4. Ignore the chartists, tea-leaf readers, technical analysts and other short-termist traders – their methods will likely never score you a ten-bagger.

I may be biased, but if you want help finding the next ten-bagger, The Motley Fool's subscription-based services and free website are your best bet.

Motley Fool writer/analyst Mike King owns shares in Capitol Health, Telstra, CSL and Woolworths. You can follow Mike on Twitter @TMFKinga

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »